PER 2.67% 7.3¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-173

  1. 2,197 Posts.
    lightbulb Created with Sketch. 160
    Does that mean the trial will be definitely a success? ANP is now officially a risk free stock?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.